Wide release: June 4, 2026. Not medical advice.
Nick Jikomes speaks with Richard Johnson about the distinct metabolic pathways of glucose and fructose and the central role of fructose in driving metabolic disease. Johnson presents his fructose survival hypothesis, arguing that fructose metabolism evolved to help animals prepare for periods of food scarcity by promoting fat storage, foraging behavior, and insulin resistance. Key concepts include the liver’s first-pass metabolism of fructose leading to ATP depletion and uric acid-driven mitochondrial oxidative stress, the separation of sugar craving from metabolic effects, and how chronic activation of this pathway in modern environments contributes to obesity, fatty liver, and Alzheimer’s-like brain changes.
TOPICS DISCUSSED:
Glucose vs Fructose Metabolism: Fructose is rapidly metabolized in the liver by fructokinase without feedback, causing ATP depletion and uric acid production, unlike glucose metabolism.
Liver Effects: Fructose induces uric acid production, NADPH oxidase activation, mitochondrial oxidative stress, and de novo lipogenesis even under caloric restriction.
Fructose Survival Hypothesis: Fructose signaling promotes fat storage, leptin resistance, foraging behavior, and metabolic syndrome as adaptations for hibernation or starvation, including metabolic water production.
Brain Impacts: Endogenous fructose production from glucose (polyol pathway) triggered by high glucose, salt, or stress leads to insulin resistance, mitochondrial damage, and neuroinflammation in Alzheimer’s-vulnerable regions.
Evolutionary Context: Human uricase mutation ~12 million years ago enhanced fructose effects for fat storage during seasonal starvation but increases vulnerability today.
Modern Triggers: Added sugars, high fructose corn syrup, salt-sugar combinations, and omega-6 fats synergize with fructose to amplify inflammation, appetite, and disease risk.
Alzheimer’s Link: Fructose-driven brain changes mirror Alzheimer’s pathology, with high brain fructose in patients and potential for fructokinase inhibitors as therapy.
ABOUT THE GUEST: Richard Johnson MD, is a professor of medicine who has conducted clinical practice and NIH-funded research on sugar metabolism since the late 1990s. His work focuses on the role of fructose in metabolic syndrome, obesity, and related diseases.
RELATED CONTENT:
Article | Dietary Fructose & Metabolic Health: An Evolutionary Perspective
M&M 249: Fructose, Microglia, Anxiety & Brain Development | Justin Perry | 249
KNOW YOURSELF:
Visit the SUPPORT PAGE if you find value in this content. Includes discount codes + links to affiliate partners, including products to help you measure and manage your health.
Listen or watch on your favorite platform:
PRACTICAL TAKEAWAYS:
Prioritize cutting liquid sugars and high fructose corn syrup, as they deliver rapid liver loads causing ATP depletion and uric acid spikes.
Reduce high glycemic carbs, especially when salted, and limit alcohol to minimize endogenous fructose production via the polyol pathway.
Favor whole fruits in season over processed foods, recognizing natural fiber and seasonal limits help buffer fructose effects.
A ketogenic approach can block both glucose and fructose survival pathways, reducing metabolic drive toward fat storage and insulin resistance.
SUBSCRIBER CONTENT BELOW: Reference paper + episode transcript.
